| Literature DB >> 25282038 |
Matthew L Carlson1, Stanley Pelosi2, David S Haynes3.
Abstract
Active middle ear implants (AMEIs) are sophisticated technologies designed to overcome many of the shortcomings of conventional hearing aids, including feedback, distortion, and occlusion effect. Three AMEIs are currently approved by the US Food and Drug Administration for implantation in patients with sensorineural hearing loss. In this article, the history of AMEI technologies is reviewed, individual component development is outlined, past and current implant systems are described, and design and implementation successes and dead ends are highlighted. Past and ongoing challenges facing AMEI development are reviewed.Entities:
Keywords: Hearing rehabilitation; Implantable hearing aids; Middle ear implant(s); Sensorineural hearing loss
Mesh:
Year: 2014 PMID: 25282038 DOI: 10.1016/j.otc.2014.08.004
Source DB: PubMed Journal: Otolaryngol Clin North Am ISSN: 0030-6665 Impact factor: 3.346